Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Bioverativ Inc. (BIVV) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/08/2018 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Amended and Restated Certificate of Incorporation of Bioverativ Inc",
"Amended and Restated Bylaws of Bioverativ Inc"
02/06/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Agent for Service of Legal Process on the Plan"
01/22/2018 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Bioverativ Inc., Sanofi and Blink Acquisition Corp",
"Letter Agreement, by and among Bioverativ Inc., Biogen Inc. and Sanofi",
"Sanofi to Acquire Bioverativ for $11.6 Billion"
10/26/2017 8-K Quarterly results
09/14/2017 8-K/A Quarterly results
08/02/2017 8-K Quarterly results
Docs: "Second quarter 2017 revenues up 37.5% year-over-year"
06/28/2017 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...
Docs: "Credit Agreement between Bioverativ Inc. and certain subsidiaries, Bank of America, N.A., as administrative agent, swing line lender and an L/C issuer, and the other lenders party thereto",
"Bioverativ Completes Acquisition of True North Therapeutics"
05/23/2017 8-K Form 8-K - Current report
05/16/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/03/2017 8-K Form 8-K - Current report
03/02/2017 8-K Form 8-K - Current report
02/02/2017 8-K Form 8-K - Current report
01/11/2017 8-K Form 8-K - Current report
01/05/2017 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy